LEADER 00873nam0-22003131i-450- 001 990000690240403321 005 20001010 035 $a000069024 035 $aFED01000069024 035 $a(Aleph)000069024FED01 035 $a000069024 100 $a20001010d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aALVAR Aalto$eBand 2. 1963 - 1970$fredaktion Karl Fleig. 210 $aZurich$cLes Editions d'Architecture Artemis$d1971. 215 $a248 p.$cill.$d24x29 cm 300 $aTesto in lingua tedesca, francese ed inglese. 610 0 $aAalto, Hugo Alvar Henrick 676 $a720.23 702 1$aFleig,$bKarl 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990000690240403321 952 $a01 DA 3007$b3117$fDINST 959 $aDINST 996 $aALVAR Aalto$9324622 997 $aUNINA DB $aING01 LEADER 01305nam--2200409---450- 001 990001186040203316 005 20031007105823.0 035 $a000118604 035 $aUSA01000118604 035 $a(ALEPH)000118604USA01 035 $a000118604 100 $a20031007d1995----km-y0itay0103----ba 101 0 $aita 102 $aIT 105 $a||||||||001yy 200 1 $a<> industria farmaceutica italiana$eprincipali caratteristiche strutturali$fdi Arturo Hermann e Sergio Sgarbi 210 $aRoma$cISPE$d1995 215 $a56 p.$cill.$d21 cm 225 2 $aDocumenti di lavoro$v31 300 $ain testa al front.: ISPE, Istituto di studi per la programmazione economica 410 0$12001$aDocumenti di lavoro$v31 454 1$12001 461 1$1001-------$12001 606 0 $aIndustria farmaceutica$yItalia 606 0 $aMedicinali$xConsumo$yItalia 676 $a338.476 151 094 5 700 1$aHERMANN,$bArturo$0118593 701 1$aSGARBI,$bSergio$0123858 801 0$aIT$bsalbc$gISBD 912 $a990001186040203316 951 $a338.476 151 094 5 HER$b1088 FARM$c338.476 959 $aBK 969 $aFAR 979 $aSIAV1$b10$c20031007$lUSA01$h1058 979 $aPATRY$b90$c20040406$lUSA01$h1725 996 $aIndustria farmaceutica italiana$9982973 997 $aUNISA